Claudius Mueller, Ph.D. - Publications

2008 Loma Linda University, Loma Linda, United States 

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Popova TG, Espina V, Zhou W, Mueller C, Liotta L, Popov SG. Whole proteome analysis of mouse lymph nodes in cutaneous anthrax. Plos One. 9: e110873. PMID 25329596 DOI: 10.1371/journal.pone.0110873  0.52
2014 Voss K, Amaya M, Mueller C, Roberts B, Kehn-Hall K, Bailey C, Petricoin E, Narayanan A. Inhibition of host extracellular signal-regulated kinase (ERK) activation decreases new world alphavirus multiplication in infected cells. Virology. 468: 490-503. PMID 25261871 DOI: 10.1016/j.virol.2014.09.005  0.52
2014 Colarossi L, Memeo L, Colarossi C, Aiello E, Iuppa A, Espina V, Liotta L, Mueller C. Inhibition of histone deacetylase 4 increases cytotoxicity of docetaxel in gastric cancer cells. Proteomics. Clinical Applications. 8: 924-31. PMID 25091122 DOI: 10.1002/prca.201400058  0.52
2014 Amaya M, Voss K, Sampey G, Senina S, de la Fuente C, Mueller C, Calvert V, Kehn-Hall K, Carpenter C, Kashanchi F, Bailey C, Mogelsvang S, Petricoin E, Narayanan A. The role of IKKβ in Venezuelan equine encephalitis virus infection. Plos One. 9: e86745. PMID 24586253 DOI: 10.1371/journal.pone.0086745  0.52
2014 Cremona M, Espina V, Caccia D, Veneroni S, Colecchia M, Pierobon M, Deng J, Mueller C, Procopio G, Lanzi C, Daidone MG, Cho WC, Petricoin EF, Liotta L, Bongarzone I. Stratification of clear cell renal cell carcinoma by signaling pathway analysis. Expert Review of Proteomics. 11: 237-49. PMID 24575852 DOI: 10.1586/14789450.2014.893193  0.52
2014 Amaya M, Baer A, Voss K, Campbell C, Mueller C, Bailey C, Kehn-Hall K, Petricoin E, Narayanan A. Proteomic strategies for the discovery of novel diagnostic and therapeutic targets for infectious diseases. Pathogens and Disease. 71: 177-89. PMID 24488789 DOI: 10.1111/2049-632X.12150  0.52
2014 Mueller C, deCarvalho AC, Mikkelsen T, Lehman NL, Calvert V, Espina V, Liotta LA, Petricoin EF. Glioblastoma cell enrichment is critical for analysis of phosphorylated drug targets and proteomic-genomic correlations. Cancer Research. 74: 818-28. PMID 24346432 DOI: 10.1158/0008-5472.CAN-13-2172  0.52
2013 Schrag M, Mueller C, Zabel M, Crofton A, Kirsch WM, Ghribi O, Squitti R, Perry G. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis. Neurobiology of Disease. 59: 100-10. PMID 23867235 DOI: 10.1016/j.nbd.2013.07.005  0.52
2013 Golubeva Y, Salcedo R, Mueller C, Liotta LA, Espina V. Laser capture microdissection for protein and NanoString RNA analysis. Methods in Molecular Biology (Clifton, N.J.). 931: 213-57. PMID 23027006 DOI: 10.1007/978-1-62703-056-4_12  0.52
2013 Petricoin EF, Leyland-Jones B, Wulfkuhle J, Pierobon M, Mueller C, Espina V, Liotta LA. Reverse Phase Protein Microarray Technology: Advances into the Clinical Research Arena Proteomic and Metabolomic Approaches to Biomarker Discovery. 349-361. DOI: 10.1016/B978-0-12-394446-7.00022-4  0.52
2012 Zabel M, Schrag M, Mueller C, Zhou W, Crofton A, Petersen F, Dickson A, Kirsch WM. Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study. Journal of Alzheimer's Disease : Jad. 30: 311-21. PMID 22426016 DOI: 10.3233/JAD-2012-112012  0.52
2012 Mueller C, Schrag M, Crofton A, Stolte J, Muckenthaler MU, Magaki S, Kirsch W. Altered serum iron and copper homeostasis predicts cognitive decline in mild cognitive impairment. Journal of Alzheimer's Disease : Jad. 29: 341-50. PMID 22232013 DOI: 10.3233/JAD-2011-111841  0.52
2012 Espina V, Mueller C. Reduction of preanalytical variability in specimen procurement for molecular profiling. Methods in Molecular Biology (Clifton, N.J.). 823: 49-57. PMID 22081338 DOI: 10.1007/978-1-60327-216-2_4  0.52
2011 Espina V, Mueller C, Liotta LA. Phosphoprotein stability in clinical tissue and its relevance for reverse phase protein microarray technology. Methods in Molecular Biology (Clifton, N.J.). 785: 23-43. PMID 21901591 DOI: 10.1007/978-1-61779-286-1_3  0.52
2011 Mueller C, Edmiston KH, Carpenter C, Gaffney E, Ryan C, Ward R, White S, Memeo L, Colarossi C, Petricoin EF, Liotta LA, Espina V. One-step preservation of phosphoproteins and tissue morphology at room temperature for diagnostic and research specimens. Plos One. 6: e23780. PMID 21858221 DOI: 10.1371/journal.pone.0023780  0.52
2011 Schrag M, Mueller C, Oyoyo U, Smith MA, Kirsch WM. Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion. Progress in Neurobiology. 94: 296-306. PMID 21600264 DOI: 10.1016/j.pneurobio.2011.05.001  0.52
2010 Mueller C, Liotta LA, Espina V. Reverse phase protein microarrays advance to use in clinical trials. Molecular Oncology. 4: 461-81. PMID 20974554 DOI: 10.1016/j.molonc.2010.09.003  0.52
2010 Espina V, Mariani BD, Gallagher RI, Tran K, Banks S, Wiedemann J, Huryk H, Mueller C, Adamo L, Deng J, Petricoin EF, Pastore L, Zaman S, Menezes G, Mize J, et al. Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival. Plos One. 5: e10240. PMID 20421921 DOI: 10.1371/journal.pone.0010240  0.52
2010 Mueller C, Zhou W, Vanmeter A, Heiby M, Magaki S, Ross MM, Espina V, Schrag M, Dickson C, Liotta LA, Kirsch WM. The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 19: 1081-91. PMID 20157261 DOI: 10.3233/JAD-2010-1303  0.52
2010 Schrag M, McAuley G, Pomakian J, Jiffry A, Tung S, Mueller C, Vinters HV, Haacke EM, Holshouser B, Kido D, Kirsch WM. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathologica. 119: 291-302. PMID 19937043 DOI: 10.1007/s00401-009-0615-z  0.52
2009 Espina V, Mueller C, Edmiston K, Sciro M, Petricoin EF, Liotta LA. Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability. Proteomics. Clinical Applications. 3: 874-882. PMID 20871745 DOI: 10.1002/prca.200800001  0.52
2009 Mueller C, Magaki S, Schrag M, Ghosh MC, Kirsch WM. Iron regulatory protein 2 is involved in brain copper homeostasis. Journal of Alzheimer's Disease : Jad. 18: 201-10. PMID 19584448 DOI: 10.3233/JAD-2009-1136  0.52
2009 Kirsch W, McAuley G, Holshouser B, Petersen F, Ayaz M, Vinters HV, Dickson C, Haacke EM, Britt W, Larseng J, Kim I, Mueller C, Schrag M, Kido D. Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. Journal of Alzheimer's Disease : Jad. 17: 599-609. PMID 19433895 DOI: 10.3233/JAD-2009-1073  0.52
2008 Olson BL, Holshouser BA, Britt W, Mueller C, Baqai W, Patra S, Petersen F, Kirsch WM. Longitudinal metabolic and cognitive changes in mild cognitive impairment patients. Alzheimer Disease and Associated Disorders. 22: 269-77. PMID 18580584 DOI: 10.1097/WAD.0b013e3181750a65  0.52
2008 Magaki S, Yellon SM, Mueller C, Kirsch WM. Immunophenotypes in the circulation of patients with mild cognitive impairment. Journal of Psychiatric Research. 42: 240-6. PMID 17320906 DOI: 10.1016/j.jpsychires.2007.01.004  0.52
2007 Magaki S, Mueller C, Yellon SM, Fox J, Kim J, Snissarenko E, Chin V, Ghosh MC, Kirsch WM. Regional dissection and determination of loosely bound and non-heme iron in the developing mouse brain. Brain Research. 1158: 144-50. PMID 17560557 DOI: 10.1016/j.brainres.2007.05.004  0.52
2007 Magaki S, Raghavan R, Mueller C, Oberg KC, Vinters HV, Kirsch WM. Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias. Neuroscience Letters. 418: 72-6. PMID 17408857 DOI: 10.1016/j.neulet.2007.02.077  0.52
2007 Magaki S, Mueller C, Dickson C, Kirsch W. Increased production of inflammatory cytokines in mild cognitive impairment. Experimental Gerontology. 42: 233-40. PMID 17085001 DOI: 10.1016/j.exger.2006.09.015  0.52
2007 Seifart U, Fink T, Schade-Brittinger C, Hans K, Mueller C, Koschel G, Schroeder H, Lorenz R, Dethling J, Wolf M. Randomised phase II study comparing topotecan/carboplatin administration for 5 versus 3 days in the treatment of extensive-stage small-cell lung cancer Annals of Oncology. 18: 104-109. PMID 17071939 DOI: 10.1093/annonc/mdl353  0.52
2006 Coon KD, Siegel AM, Yee SJ, Dunckley TL, Mueller C, Nagra RM, Tourtellotte WW, Reiman EM, Papassotiropoulos A, Petersen FF, Stephan DA, Kirsch WM. Preliminary demonstration of an allelic association of the IREB2 gene with Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 9: 225-33. PMID 16914832  0.52
2005 Seifart U, Jensen K, Ukena J, Mueller C, Schröder M, Fuhr HG, Keppler U, Neubauer A, Staab HJ, Wolf M. Randomized phase II study comparing topotecan/cisplatin administration for 5 days versus 3 days in the treatment of extensive stage small cell lung cancer (SCLC) Lung Cancer. 48: 415-422. PMID 15893011 DOI: 10.1016/j.lungcan.2004.12.003  0.52
Show low-probability matches.